PPPooja Patel

Pooja Patel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Pooja Patel has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Pulmonary Vein Isolation (PVI) Versus PVI With Posterior Wall Isolation With PFA for Paroxysmal Atrial Fibrillation

    by Joey Junarta, Angela Wang, Eli Reynolds, Aristides Hatzimemos, Pooja Patel, Danielle Shields, Felix Yang, Chirag R. Barbhaiya, Lior Jankelson, Douglas Holmes, et al.

    Background: The value of additional lesion sets beyond pulmonary vein isolation (PVI) for atrial fibrillation (AF) ablation is unclear. However, existing studies evaluated the utility of substrate modification with conventional energy sources. There is limited data evaluating PVI with posterior wall isolation (PWI) using pulsed field ablation (PFA). Methods: We studied consecutive cases of patients with paroxysmal AF undergoing first‐time ablation with PFA between May 6, 2024 and March 10, 2025. Procedural data collected included the number of PFA applications administered, total procedure time, and major periprocedural complications. Clinical data collected included atrial tachyarrhythmia (ATA) recurrence, stroke, and major bleeding at 1‐year follow‐up. Outcomes were compared in patients undergoing PVI alone versus PVI plus PWI. Results: A total of 249 patients were included in this study (104 PVI alone, 145 PVI plus PWI). There was no difference in ATA recurrence by Kaplan–Meier survival analysis comparing PVI alone versus PVI plus PWI (log rank test p = 0.89). When comparing PVI alone versus PVI plus PWI, there was no difference in ATA recurrence at 1 year (16% vs. 16%; p = 0.92), AF burden on continuous monitoring (2% vs. 2%; p = 0.81), total procedure time (114 vs. 107 min; p = 0.14), or major periprocedural complications (0 vs. 3; p = 0.14). Conclusion: PFA for paroxysmal AF with PVI alone or PVI plus PWI produces similar sinus rhythm maintenance without affecting procedure times or complication rates.

  • The Utility of Higher Pulsed Field Ablation Applications for Atrial Fibrillation Ablation

    by Joey Junarta, Eli Reynolds, Angela Wang, Aristides Hatzimemos, Pooja Patel, Danielle Shields, Felix Yang, Chirag R. Barbhaiya, Lior Jankelson, Douglas Holmes, et al.

    Background: The optimal number of pulsed field ablation (PFA) applications during atrial fibrillation (AF) ablation is unclear. We hypothesized that the number of PFA applications would predict atrial tachyarrhythmia (ATA) recurrence rates. Objective: To determine whether higher numbers of PFA applications would decrease ATA recurrence rates. Methods: We studied cases of patients with AF undergoing first‐time ablation with PFA between 5/6/24 and 10/7/24. All patients underwent pulmonary vein and posterior wall isolation. The primary outcome was ATA recurrence. Additional outcomes included stroke, post‐procedural acute kidney injury (AKI), total procedure time, and major periprocedural complications. Univariable and multivariable analyses were performed to determine if the number of PFA applications predicted ATA recurrence. Results: In a cohort consisting of 177 patients, univariable and multivariable analysis showed that the number of PFA applications split at the smallest quartile (< 57 applications) versus the largest three quartiles (≥ 57 applications) was the strongest predictor of ATA recurrence ( p = 0.03). ATA recurrence at 1 year (29% vs. 8%; p < 0.01) and AF burden on continuous monitor (4% vs. 0%; p < 0.01) was higher with the standard (< 57 applications) vs higher (≥ 57 applications) PFA dose groups. When comparing the standard versus higher PFA dose groups, there was no difference in total procedure time (106 vs. 107 min; p = 0.77), major periprocedural complications (0% vs. 2%; p = 0.33), or post‐procedural AKI (2% vs. 2%; p = 0.69). Conclusion: Increasing number of PFA applications is associated with reduced ATA recurrence. A higher number of PFA applications may decrease ATA recurrence without affecting procedure times or complication rate.

  • 5-Methylcytosine RNA Modifications Promote Retrovirus Replication in an ALYREF Reader Protein-Dependent Manner

    by Matthew Eckwahl, Ruyi Xu, Julia Michalkiewicz, Wen Zhang, Pooja Patel, Zhen Cai, Tao Pan

    Over 130 modifications have been identified in cellular RNAs, which play critical roles in many cellular processes, from modulating RNA stability to altering translation efficiency. One such modification, 5-methylcytosine, is relatively abundant in mammalian mRNAs, but its precise location and function are not well understood. In this study, we identified unexpectedly high levels of m 5 C in the murine leukemia virus RNA, precisely mapped its location, and showed that ALYREF, a reader protein that specifically recognizes m 5 C, regulates viral production. Together, our findings provide a high-resolution atlas of m 5 C in murine leukemia virus and reveal a functional role of m 5 C in viral replication.